Article Text

other Versions


A multicentre, randomised, double-blind, placebo controlled phase II study of subcutaneously administered interferon beta 1a in the treatment of patients with active rheumatoid arthritis

Statistics from

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.